The Polish Competition Authority (UOKiK) has issued Decision No DKK-216/2026 on October 1, 2026, approving the merger between PharmaBio Investments Inc., based in Durham, USA, and Nova Aqua Limited, located in Tortola, British Virgin Islands. This decision follows an antitrust investigation initiated at the request of the two companies.

The merger involves the establishment of a joint venture as outlined in their application. The authority determined that the merger does not raise any competition concerns and therefore did not require any remedies or further investigation.

Notably, the decision did not include a detailed justification as it fully complied with the requests of the parties involved and did not address any contentious interests. The approval allows the companies to proceed with their plans without any imposed conditions.

Parties have the right to appeal this decision to the District Court in Warsaw within one month of receiving the notification, with a fixed court fee of 1000 PLN applicable for the appeal.